Guidelines recommend coronary artery bypass graft surgery (CABG) over percutaneous coronary intervention (PCI) for multivessel disease and severe left ventricular systolic dysfunction. However, CABG has not been compared with PCI in such patients in randomized trials. Using data from the New York State registries, we identified 4616 patients with multivessel disease and severe left ventricular systolic dysfunction (ejection fraction ≤35%) who underwent either PCI with everolimus-eluting stent or CABG. Propensity score matching identified 2126 patients with similar propensity scores. In the short term, PCI was associated with a lower risk of stroke in comparison with CABG. At long-term follow-up (median, 2.9 years), PCI was associated with a similar risk of death, a higher risk of myocardial infarction (in those with incomplete revascularization), a lower risk of stroke, and a higher risk of repeat revascularization. PCI with newer-generation drugeluting stents, in selected patients with left ventricular dysfunction, may therefore be an acceptable alternative to CABG in patients in whom complete revascularization is possible. The results are hypothesis generating and should be tested in future clinical trials. See p 2132.
Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study
This report from the Atherosclerosis Risk in Communities (ARIC) study, one of the largest community-based biracial cohort studies in the United States, shows that the presence of asymptomatic or silent myocardial infarction on screening ECGs is a common finding; ≈45% of the total number of myocardial infarctions in the study were silent. These silent myocardial infarctions were associated with increased risk of death in a magnitude that is relatively comparable to that of myocardial infarctions with clinical manifestations. However, race and sex differences in the incidence and prognostic significance of silent myocardial infarction were observed in this study. These findings highlight the importance of detecting silent myocardial infarctions and the potential impact of such detection on personalized prevention of coronary heart disease that takes into account race and sex. See p 2141.
Reproductive Risk Factors and Coronary Heart Disease in the Women's Health Initiative Observational Study
When considered together, the following reproductive factors are independently associated with postmenopausal coronary heart disease in women: early age at first birth, number of stillbirths and miscarriages, irregular menses, and lack of breastfeeding for ≥1 months. When considered along with established risk factors, these reproductive factors do not improve our ability to risk stratify coronary heart disease in postmenopausal women. However, our study suggests that a reproductive history may be useful as an early window, before the onset of established coronary heart disease risk factors, to predict which women are most likely to experience a future coronary heart disease event. See p 2149.
Regional Variation in Out-of-Hospital Cardiac Arrest Survival in the United States
Out-of-hospital cardiac arrest is common and associated with poor survival and neurological outcomes. Although previous studies have documented marked variation in out-of-hospital cardiac arrest survival based on geography, few studies have examined factors that explain survival variation across communities. Using data from a large registry of out-of-hospital cardiac arrests in the United States, we found a marked variation in rates of survival to discharge (range, 3.4%-22.0%; median odds ratio, 1.40) and survival with functional recovery (range, 0.7%-16.2%; median odds ratio, 1.60) across US counties. County-level rates of bystander cardiopulmonary resuscitation and bystander automated external defibrillator use were positively correlated with both outcomes (P<0.0001 for all). Patient demographic and cardiac arrest characteristics explained 4.8% and 27.7% of the county-level variation in survival, respectively. Additional adjustment of bystander response explained 41% of the survival variation, and this increased to 50.4% after adjustment of county-level sociodemographic factors. Similar findings were noted in analyses of survival with functional recovery. Importantly, a substantial proportion of explained variation in survival across communities was attributable to variation in rates of bystander cardiopulmonary resuscitation -a factor that is most amenable to intervention. Collectively, our findings highlight large variation in survival outcomes for out-of-hospital cardiac arrest and suggest that public health interventions, such as those that improve rates of bystander cardiopulmonary resuscitation, have the potential to improve the low survival rates for this condition. See p 2159.
Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease
The brain is highly susceptible to ischemia/reperfusion injury, so prevention of cerebral ischemic events has become a major part of modern health care. However, neuronal cells have a limited capacity for restoration after cerebral ischemia/reperfusion; therefore, there is an unmet clinical need to explore novel therapeutic avenues to better resolve the aggressive inflammatory state after cerebral ischemic insults to limit irrecoverable neuronal damage. Our study shows for the first time the novel role of AnxA1 Ac2-26 and aspirintriggered lipoxin in regulating leukocyte-platelet responses Volume 133 ◼ Number 22 ◼ May 31, 2016
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in the cerebral microvasculature after ischemia/reperfusion. These results were attained by pharmacological blockade, quantification of endogenous mediator levels, and the use of formyl-peptide receptor 2/3-deficient (Fpr2/3 −/− ) mice. Furthermore, we demonstrate that specifically neutrophil Fpr2/3 regulates cerebral neutrophil-platelet aggregation by rapid generation of aspirin-triggered lipoxin in an endogenous biosynthetic circuit. This pathway helps to resolve inflammation and to restore homeostasis. This has been shown for the first time in the brain, and we feel that these data are exciting because they confirm that Fpr2/lipoxin A 4 receptor is a therapeutic target for initiating endogenous proresolving, anti-inflammatory pathways after cerebral ischemia/reperfusion injury, which has clear clinical implications in helping to limit neuronal damage after ischemic insults. See p 2169.
